Pharmafile Logo

How smart spaces and real-time strategy transformed ASCO® 2025

August 19, 2025 | Congress, Inizio, oncology 

- PMLiVE

Nick Bellomo, Director of Technology and Engagement, Inizio Medical

ASCO® 2025 wasn’t just about oncology breakthroughs – it was also a showcase for how technology is redefining congress engagement. Supporting dozens of clients with hundreds of deliverables, Inizio had a front-row seat to innovations that are reshaping how healthcare professionals (HCPs) learn and interact.

Highlights from the floor:

  • LED walls reimagined: Once static displays, LED walls are now interactive storytelling tools. From gesture-responsive MOAs to live trial dashboards, these experiences empowered HCPs to navigate content at their own pace, boosting engagement and driving more meaningful conversations.

  • Real-time in-booth analytics: Inizio piloted offline analytics that delivered live insights without internet dependency. This allowed brands to refine content mid-show, optimize staff alignment, and deliver more targeted education – all during the congress, not weeks later.

Why it matters:
These shifts mark a broader transformation: moving from passive storytelling to responsive engagement, and from delayed insights to real-time adaptability. For HCPs, this means richer, more relevant learning. For brands, it means smarter strategies and more impactful outcomes.

At Inizio, the booth is no longer just a backdrop – it’s a catalyst for strategic engagement and patient-focused progress.

Read the full article authored by Nick here. Discover more in the on-demand webinar Beyond the booth: Big ideas, smart spaces & strategic insights from ASCO® 2025.

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Webcast

Monitoring the impact of COVID-19 on the market access landscape

Live webinar from Singapore

Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19

Guide

UX research

Article: Why pharma must trust the science of behaviour

In a recent interview with PME Magazine, Dan Coffin, Director explains why the application of behavioural science will be key to better health far beyond COVID-19.Read the full article here:...

Case study

Using qualitative conjoint to assess willingness-to-pay

Consumer health specialist joins Research Partnership Inc

Global healthcare market research consultancy Research Partnership has appointed Jennifer Stewart as a Director in their US offices in Philadelphia.

Article: What’s next? How behavioural science can support pharma’s future

Dan Coffin, Director explains why now is an opportune time for pharma marketers to embrace behavioural science. Read his latest article for PME Magazine.https://bit.ly/31ef6rh

Video: UX/ Experience design research

Director and UX expert Liza Pliss discusses Research Partnership's approach to user experience research and shares an example of a project where using design thinking led to an agile approach...

White paper: The impact of COVID-19 on chronic disease management

Therapy Watch, Research Partnership's syndicated PRF tracker, has been investigating the impact of COVID-19 on chronic disease management. In this white paper, Research Partnership share some of the insights and...

Article: Pricing a coronavirus vaccine

Using findings from Research Partnership's recent COVID-19 impact study, Market Access Directors Rachel Howard and Brett Gardiner and Consultant Suzan Serip explore the challenges of pricing a coronavirus vaccine. Read...